# Phase 2 Parkinson Disease trials recruiting: 45 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 45 trials in phase 2 for Parkinson Disease that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting Phase 2 Parkinson Disease trials: 45 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 2 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/phase-2/parkinson-disease

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 45
- Recruiting or not yet: 45
- Read on: November 19, 2026

## Trials

The 25 newest of 45, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| October 29, 2026 | NCT07903038 | Lemborexant on Perioperative Sleep Quality in Patients With Parkinson's Disease Undergoing Deep Brain Stimulation | Beijing Tiantan Hospital | Phase 2 | Not yet recruiting | Parkinson Disease (PD), Sleep Initiation and Maintenance Disorders, Deep Brain Stimulation | 128 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07903038) |
| September 21, 2026 | NCT07830654 | This Protocol is a Sub-study Under the PPMI Program. It is a Longitudinal, Single-center Study to Assess the Performance of \[18F\]AV-133... | Michael J. Fox Foundation for Parkinson's Research | Phase 2 | Recruiting | Parkinson's Disease (PD), Healthy Control Subjects | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07830654) |
| September 4, 2026 | NCT07804615 | A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently... | Vima Therapeutics | Phase 2 | Recruiting | PARKINSON DISEASE (Disorder) | 80 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07804615) |
| September 4, 2026 | NCT07804381 | Disease-modifying Efficacy of Sitagliptin Therapy in Early-stage Parkinson's Disease | Yonsei University | Phase 2 | Not yet recruiting | Parkinson Disease | 160 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07804381) |
| August 24, 2026 | NCT07781644 | Study to Test Effects and Safety of RO7568282 in Early Parkinson's Disease | Hoffmann-La Roche | Phase 2 | Recruiting | Parkinson's Disease | 474 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07781644) |
| June 15, 2026 | NCT07647614 | A Study to Evaluate the Efficacy and Safety of ENERGI-F705 Tablets for Parkinson's Disease | Energenesis Biomedical Co., Ltd. | Phase 2 | Not yet recruiting | Parkinson's Disease (PD) | 105 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07647614) |
| May 28, 2026 | NCT07610369 | The Efficacy of Psilocybin Therapy for Depression in Parkinson's Disease | Yale University | Phase 2 | Recruiting | Depression, Parkinson's Disease (PD) | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07610369) |
| May 18, 2026 | NCT07592767 | RESvEraTrol in Parkinson's Disease (RESET) | Georgetown University | Phase 2 | Recruiting | Parkinson's Disease | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07592767) |
| May 13, 2026 | NCT07585565 | A Study to Evaluate the Efficacy and Safety of Monosialotetrahexosylganglioside Sodium Injection in Parkinson's Disease Participants With... | Qilu Pharmaceutical Co., Ltd. | Phase 2 | Not yet recruiting | Parkinson's Disease | 276 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07585565) |
| May 5, 2026 | NCT07566429 | A Study of AB-1005 Gene Therapy in Japanese Adults With Moderate Parkinson's Disease (J-REGENERATE-PD) | Bayer | Phase 2 | Not yet recruiting | Parkinson Disease | 8 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07566429) |
| April 7, 2026 | NCT07514858 | A Trial Investigating Lu AF28996 in Adults With Parkinson's Disease Who Have Motor Fluctuations | H. Lundbeck A/S | Phase 2 | Recruiting | Parkinson's Disease | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07514858) |
| March 13, 2026 | NCT07471230 | Evaluation of Neuroinduced Mesenchymal Stem Cells and Mesenchymal Stem Cell-Derived Exosomes in Patients With Parkinsonism | Biocells Medical | Phase 2 | Not yet recruiting | Parkinsonism or Parkinson's Disease Nos, Parkinsonism in Diseases Classified Elsewhere | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07471230) |
| March 2, 2026 | NCT07442747 | Neural Mechanisms of Aerobic Exercise Benefits in PD With DBS | The Cleveland Clinic | Phase 2 | Recruiting | Parkinson's Disease, Deep Brain Stimulation | 36 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07442747) |
| February 25, 2026 | NCT07432958 | A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants... | Appello Pharmaceuticals, Inc. | Phase 2 | Recruiting | Parkinson Disease | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07432958) |
| January 27, 2026 | NCT07370532 | Etoricoxib in Patients With Parkinsonian Disease | Sponsor not shown (see the record) | Phase 2 | Recruiting | Parkinson Disease | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07370532) |
| January 26, 2026 | NCT07366411 | taVNS on Functional Mobility in People With DP | Universidade Federal de Pernambuco | Phase 2 | Not yet recruiting | PARKINSON DISEASE (Disorder) | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07366411) |
| January 7, 2026 | NCT07322887 | A Phase 2 Study to Assess the Effects of SUL-238 on High Energy Phosphates With ³¹P-MRS in Patients With Early, Untreated Parkinson's... | GEN İlaç ve Sağlık Ürünleri A.Ş. | Phase 2 | Recruiting | Parkinson's Disease (PD) | 45 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07322887) |
| December 31, 2025 | NCT07312110 | D-SPARK: A Clinical Trial of D-Serine for Modifying Parkinson's Disease Progression | Haukeland University Hospital | Phase 2 | Recruiting | Parkinson s Disease, Parkinson Disease (PD) | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07312110) |
| December 19, 2025 | NCT07294469 | Menthol for Improving Movement and Sleep in Parkinson's Disease Patients | Taipei Medical University Hospital | Phase 2 | Not yet recruiting | Parkinson's Disease | 80 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07294469) |
| December 12, 2025 | NCT07280299 | Efficacy, Safety, Tolerability, and Biomarker Effects of GT-02287 in Early Parkinson's Disease | Gain Therapeutics, Inc. | Phase 2 | Not yet recruiting | Parkinson Disease | 111 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07280299) |
| October 10, 2025 | NCT07215403 | Open-Label, Multi-Stage Study to Optimize the Intraputaminal Administration of AB-1005 Using a Prescriptive Infusion Algorithm (PIA) | AskBio Inc | Phase 2 | Not yet recruiting | PARKINSON DISEASE (Disorder) | 18 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07215403) |
| September 16, 2025 | NCT07176286 | 18F-mFBG Cardiac Uptake With Lewy Body Dementia | Innervate Radiopharmaceuticals LLC (Formerly: Illumina Radiopharmaceuticals LLC) | Phase 2 | Recruiting | Parkinson Disease (PD), Lewy Body Dementia (LBD) | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07176286) |
| September 5, 2025 | NCT07157735 | A Trial to Test the Use of Dapansutrile, an Anti-inflammatory Medication, in People With Parkinson's Disease | Cambridge University Hospitals NHS Foundation Trust | Phase 2 | Recruiting | Parkinson Disease | 36 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07157735) |
| September 5, 2025 | NCT07156773 | The Study is Being Conducted to Evaluate the Safety and Efficacy of XJN010 Nasal Spray in Patients With Parkinson's Disease Experiencing... | Guangzhou Novaken Pharm Co., Ltd. | Phase 2 | Recruiting | Parkinson Disease | 84 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07156773) |
| July 8, 2025 | NCT07055087 | Prevent Cognitive Decline in GBA-associated Parkinson's Disease | University Hospital Tuebingen | Phase 2 | Recruiting | Parkinson's Disease | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07055087) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| Yale University | 2 |
| Michael J. Fox Foundation for Parkinson's Research | 2 |
| Vima Therapeutics | 1 |
| [Hoffmann-La Roche](https://specstream.ai/data/clinical-trials/company/hoffmann-la-roche) | 1 |
| Laboratorio Elea Phoenix S.A. | 1 |
| University of Illinois at Urbana-Champaign | 1 |
| Teachers College, Columbia University | 1 |
| Yonsei University | 1 |
| Appello Pharmaceuticals, Inc. | 1 |
| AskBio Inc | 1 |
| Mthera Pharma Co., Ltd. | 1 |
| Haukeland University Hospital | 1 |
| InnoMedica Schweiz AG | 1 |
| [H. Lundbeck A/S](https://specstream.ai/data/clinical-trials/company/h-lundbeck-a-s) | 1 |
| [Bayer](https://specstream.ai/data/clinical-trials/company/bayer) | 1 |
| Biocells Medical | 1 |
| Energenesis Biomedical Co., Ltd. | 1 |
| Cambridge University Hospitals NHS Foundation Trust | 1 |
| Georgetown University | 1 |
| University Hospital, Toulouse | 1 |
| Guangzhou Novaken Pharm Co., Ltd. | 1 |
| [Qilu Pharmaceutical Co., Ltd.](https://specstream.ai/data/clinical-trials/company/qilu-pharmaceutical-co-ltd) | 1 |
| Ralph H. Johnson VA Medical Center | 1 |
| Beijing Tiantan Hospital | 1 |
| VA Office of Research and Development | 1 |

## By country

| Country | Trials |
| --- | --- |
| United States | 22 |
| Poland | 4 |
| United Kingdom | 4 |
| China | 3 |
| Canada | 2 |
| Czechia | 2 |
| Germany | 2 |
| Taiwan | 2 |
| France | 2 |
| Netherlands | 2 |
| Italy | 2 |
| Spain | 2 |
| Ireland | 1 |
| Argentina | 1 |
| Egypt | 1 |
| Norway | 1 |
| Switzerland | 1 |
| Japan | 1 |
| Brazil | 1 |
| Denmark | 1 |
| Portugal | 1 |
| Luxembourg | 1 |
| Sweden | 1 |
| Israel | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Tea wholesalers in the United States](https://specstream.ai/data/businesses/tea-wholesalers/united-states)
- [Manufacturers in the United States](https://specstream.ai/data/businesses/manufacturers/united-states)
- [Dental clinics in the United States](https://specstream.ai/data/businesses/dental-clinics/united-states)
- [Wallpaper installers in the United States](https://specstream.ai/data/businesses/wallpaper-installers/united-states)
- [Office supply stores in the United States](https://specstream.ai/data/businesses/office-supply-stores/united-states)
- [Environmental abatement companies in the United States](https://specstream.ai/data/businesses/environmental-abatement-companies/united-states)
